Controlled release of GDNF reduces nerve root-mediated behavioral hypersensitivity

Area of Science:

• Biomaterials Science
• Neuroscience
• Regenerative Medicine

Background:

• Nerve root compression causes persistent pain and behavioral sensitivity.
• Glial cell line-derived neurotrophic factor (GDNF) shows potential for treating nerve injury.
• Effective delivery of therapeutic agents to injured nerve roots remains a challenge.

Purpose of the Study:

• To develop and evaluate degradable poly(ethylene glycol) hydrogels for sustained delivery of GDNF to injured nerve roots.
• To assess the efficacy of GDNF-loaded hydrogels in reducing pain sensitivity in a rat model of nerve root compression.

Main Methods:

• Degradable poly(ethylene glycol) hydrogels were synthesized and characterized for GDNF release kinetics in vitro.
• In vitro studies assessed the effect of GDNF on neural cell outgrowth.
• A rat model of C7 dorsal root compression was used to evaluate the in vivo efficacy of GDNF hydrogel treatment.
• Mechanical allodynia was measured, and GDNF receptor (GFRalpha-1) expression in dorsal root ganglion neurons was analyzed.

Main Results:

• In vitro, hydrogels released approximately 98% of encapsulated GDNF over 7 days and promoted neural cell process outgrowth.
• In vivo, GDNF hydrogel treatment significantly decreased mechanical allodynia compared to vehicle hydrogel, bolus GDNF injection, or no treatment.
• GDNF hydrogel treatment significantly increased GDNF receptor (GFRalpha-1) immunoreactivity in dorsal root ganglion neurons compared to control groups.

Conclusions:

• Degradable hydrogels provide an effective sustained delivery system for GDNF to injured nerve roots.
• GDNF hydrogel treatment demonstrates significant therapeutic potential for alleviating nerve root-mediated pain.
• This approach offers a promising strategy for managing neuropathic pain associated with nerve root compression.